证券日报网讯 1月16日，何氏眼科在互动平台回答投资者提问时表示，公司围绕"智慧光明城"为战略目 标，已构建"互联网+医疗健康"全生命周期眼健康管理平台。公司在眼科智能化应用方面，集成智能辅 助诊断系统，建设眼科专科智能影像云平台，开发多模态数据融合决策系统。依托深度学习算法助力健 康管理，何氏眼科"何氏糖管家"结合动态血糖监测设备，实时监测血糖水平，通过数据分析、医患交互 平台以及个性化健康管理方案，实现糖尿病患者全生命周期的精准血糖控制与眼病防控。此外，何氏眼 科"光明小屋"以智能眼科设备为入口，结合线上线下诊疗体系，通过智能诊断技术筛查眼部疾病及相关 慢性病，打造数字技术赋能的基层眼健康管理场景。上述业务目前对公司主营业务及业绩未产生重大影 响，若有重大进展或触及信息披露要求，公司将依规履行信息披露义务。 （文章来源：证券日报） ...

中证报中证网讯(记者宋维东)中国证券报记者1月13日从何氏眼科（301103）获悉，何氏眼科日前成为 全国眼科联盟人工智能分联盟成员单位，在智慧医疗与人工智能临床应用领域进一步融入国家级前沿创 新平台，为提升诊疗水平、增强科研创新能力提供了重要支撑。何氏眼科相关负责人对中国证券报记者 表示，公司将以此为契机，依托联盟平台与资源优势，持续深化产学研国际合作，拓展人工智能在各类 眼科疾病筛查中的应用，推动科技创新与产业创新深度融合，让优质眼健康服务惠及更广大基层群众。 当前，人工智能、大数据等前沿技术正推动医疗服务向智能化、精准化、个性化方向发展。为促进眼科 人工智能技术发展、加快相关大模型推广应用，全国眼科联盟人工智能分联盟于2025年1月4日成立。目 前，联盟成员单位已超过百家，依托"伏羲慧眼云平台"大模型的多模态本地训练优势，持续推动优质诊 疗资源下沉，赋能基层眼科服务，让群众在家门口就能享受到优质、高效、便捷的眼健康服务。 作为以创新科技为驱动、聚焦全生命周期眼健康管理的数字眼健康生态产业集团，何氏眼科以构建"智 慧光明城"为愿景，联合辽宁何氏医学院、何氏眼产业集团、眼基因库等机构，形成协同创新矩阵。何 ...

在深耕国内市场的同时，何氏眼科还积极响应共建"一带一路"倡议，联合辽宁何氏医学院、何氏眼产业 集团等合作伙伴，推动中国眼科防盲技术与经验走向国际。通过人才培养、技术分享与防盲模式建设等 方式，将基于人工智能与大数据的创新筛查技术和管理模式推广至"一带一路"共建国家，助力提升当地 基层眼健康服务能力。 何氏眼科方面表示，将以此次加入全国眼科联盟人工智能分联盟为契机，依托联盟平台与资源优势，持 续深化产学研国际合作，拓展人工智能在各类眼科疾病筛查中的应用，推动科技创新与产业创新深度融 合，让优质眼健康服务惠及更广大基层群众，为健康中国建设和全球眼健康事业贡献力量。 本报讯(记者李勇)《证券日报》记者1月13日从辽宁何氏眼科（301103）医院集团股份有限公司(以下简 称"何氏眼科")获悉，何氏眼科于近日正式成为全国眼科联盟人工智能分联盟成员单位。这也标志着何 氏眼科在智慧医疗与人工智能临床应用领域进一步融入国家级前沿创新平台，为其提升诊疗水平、增强 科研创新能力提供了重要支撑。 为促进眼科人工智能技术发展，加快相关大模型推广应用，全国眼科联盟人工智能分联盟于2025年1月4 日正式成立。目前，联盟成员单位已超过百 ...

近日，何氏眼科(301103)正式成为全国眼科联盟人工智能分联盟成员单位，这标志着何氏眼科在智慧医 疗与人工智能临床应用领域进一步融入国家级前沿创新平台，为其提升诊疗水平、增强科研创新能力提 供了重要支撑。 在深耕国内市场的同时，何氏眼科积极响应"一带一路"倡议，联合辽宁何氏医学院、何氏眼产业集团等 合作伙伴，推动中国眼科防盲技术与经验走向国际。通过人才培养、技术分享与防盲模式建设等方式， 将基于人工智能与大数据的创新筛查技术和管理模式推广至共建"一带一路"国家和地区，助力提升当地 基层眼健康服务能力，为世界提供可复制、可推广、可持续的智慧眼健康生态"中国样本"。 何氏眼科表示，公司将以加入全国眼科联盟人工智能分联盟为契机，依托联盟平台与资源优势，持续深 化产学研国际合作，拓展人工智能在各类眼科疾病筛查中的应用，推动科技创新与产业创新深度融合， 让优质眼健康服务惠及更广大基层群众，为健康中国建设和全球眼健康事业贡献力量。（燕云） 作为以创新科技为驱动、聚焦全生命周期眼健康管理的数字眼健康生态产业集团，何氏眼科以构建"智 慧光明城"为愿景，联合辽宁何氏医学院、何氏眼产业集团、眼基因库等机构，形成协同创新矩阵。集 ...

Core Viewpoint - He Eye Hospital (301103) is leveraging intelligent systems in ophthalmology, integrating smart algorithms for diagnostic assistance and developing a specialized cloud platform for ophthalmic imaging [1] Group 1: Intelligent Systems and Applications - The company has integrated an intelligent algorithm-assisted diagnostic system and built a specialized ophthalmic imaging cloud platform [1] - A multi-modal data fusion decision system has been developed, generating a 3D digital twin model for eye health [1] - The "He Diabetes Manager" utilizes deep learning algorithms and dynamic blood glucose monitoring devices to provide real-time glucose level tracking and personalized health management for diabetes patients [1] Group 2: Digital Health Management - The company aims to achieve precise glucose control and eye disease prevention for diabetes patients throughout their life cycle [1] - The "Bright House" initiative combines online and offline ophthalmic diagnostic systems, utilizing advanced intelligent diagnostics to identify eye diseases and chronic conditions [1] - The initiative focuses on empowering grassroots eye health management through digital intelligent technology [1] Group 3: Corneal Molding Lens Fitting - In the field of corneal molding lens fitting, the company has established an algorithm model based on intelligent algorithms to enhance fitting efficiency [1] - Current business developments have not significantly impacted the company's main operations or performance [1] - The company will comply with regulatory requirements for information disclosure if there are significant advancements or if disclosure standards are met [1]

Core Insights - The company is focusing on integrating intelligent systems in ophthalmology, including the development of a smart imaging cloud platform and a multi-modal data fusion decision system, aimed at enhancing health management for diabetes patients and eye disease prevention [1] - The third quarter report for 2025 shows a revenue of 295 million yuan, a year-on-year increase of 5.37%, and a net profit attributable to shareholders of 10.07 million yuan, a significant increase of 230.99% [1] - For the first three quarters of 2025, the company reported a revenue of 855 million yuan, a year-on-year decrease of 1.11%, while the net profit attributable to shareholders was 54.40 million yuan, reflecting a year-on-year increase of 232.18% [2] Group 1 - The company has developed a diabetes management system called "He’s Sugar Manager," which utilizes deep learning algorithms and real-time blood glucose monitoring to provide personalized health management solutions [1] - The "Bright House" initiative combines online and offline ophthalmic diagnostic systems to enhance the detection of eye and chronic diseases through advanced intelligent diagnostics [1] - The company has established an algorithm model for orthokeratology lens fitting based on intelligent algorithms, improving fitting efficiency through deep learning [1] Group 2 - The company has implemented measures to improve the quality and efficiency of medical services, optimize the supply chain, and reduce operational costs, contributing to its financial performance [2] - The focus on high-margin refractive and optometry businesses has been a key strategy in the company's ongoing development [2]

Core Insights - He Eye Hospital has been awarded the "2025 Annual Listed Company ESG Value Transmission Award" and the "2025 Annual Listed Company AI Frontier Innovation Award" for its continuous efforts in ESG value transmission and pioneering applications of artificial intelligence in ophthalmology [1] Group 1: ESG Commitment - He Eye Hospital has been dedicated to the field of eye health for 30 years, focusing on prevention and treatment, and providing specialized ophthalmic diagnosis and vision care services [2] - As of June 30, 2025, the company operates 127 ophthalmic service institutions across key regions in China, aligning with the "Healthy China" strategy and the United Nations Sustainable Development Goals [2] - The company has trained over 50,000 grassroots doctors and eye health management personnel, contributing to a people-centered eye health system [2] Group 2: AI Innovations - The recognition of the AI Frontier Innovation Award highlights He Eye Hospital's technological innovation and clinical implementation capabilities in smart healthcare [3] - The company has integrated AI technology into its operations, enhancing efficiency in data collection and analysis, and optimizing clinical services through an AI imaging cloud platform [3] - The "He Diabetes Manager" utilizes AI deep learning algorithms for real-time blood sugar monitoring, aiming for precise diabetes management and eye disease prevention [3] Group 3: Refractive Surgery Advancements - In the field of refractive surgery, AI technology is applied to create personalized models for corneal aberration data, shifting surgical decision-making from experience-based to data-driven [4] - AI technology aids in preoperative risk assessment by intelligently analyzing eye images, enhancing surgical safety and control [4] - The integration of AI with visualization systems allows for better patient experience by presenting postoperative outcomes and optimizing surgical processes [4]